Loading clinical trials...
Loading clinical trials...
Double Filtration Plasmapheresis (DFPP) in Combination With Pegylated Interferon Alfa-2a and Ribavirin for Patients With Chronic Hepatitis C With Genotype 1 and High Viral Load: a Randomized Controlled Trial
Conditions
Interventions
DFPP + Peg-IFN + RBV
Peg-IFN + RBV
Locations
6
Taiwan
Buddhist Tzu Chi General Hospital
Chiayi City, Taiwan
Chiayi Christian Hospital
Chiayi City, Taiwan
National Taiwan University Hospital, Yun-Lin Branch
Douliu, Taiwan
Far Eastern Memorial Hospital
Taipei, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Taipei Municipal Hospital
Taipei, Taiwan
Start Date
September 1, 2009
Primary Completion Date
December 1, 2012
Completion Date
December 1, 2012
Last Updated
December 20, 2012
NCT06953479
NCT03135886
NCT05968573
NCT05042544
NCT05870969
NCT05361603
Lead Sponsor
National Taiwan University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions